Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ADAM | FDMT |
|---|---|---|
| Price | $7.45 | $12.29 |
| Change today | ▼ 0.53% | ▼ 2.38% |
| Market cap | $669.60M | $678.95M |
| Return, 3 months | -16.0% | -4.7% |
| Return, year to date | +12.5% | +63.9% |
| Return, 1 year | +22.8% | +27.2% |
| P/E (TTM) | 4.4 | -4.7 |
| P/B | 0.7 | 1.7 |
| P/E percentile vs own 5y | 60th | 38th |
| Dividend yield | 12.89% | – |
| Revenue growth (YoY, latest qtr) | +100.7% | +25,106.7% |
| Net profit growth (YoY) | +1,094.9% | -33.4% |
| Gross margin | – | – |
| Operating margin | – | -214.2% |
| Net margin | 38.0% | -194.7% |
| Return on equity | 17.4% | -43.3% |
| Analyst target vs. price | +30.1% | +147.6% |
| Analyst buy share | 50% | 89% |
| RSI (14) | 17 | 36 |
| 30-day volatility | 23.4% | 49.1% |
| Max drawdown, 1 year | -24.2% | -41.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
